South Korea

SNUBH to launch Korea’s first int'l PSP Research and Treatment Centre

The centre will facilitate treatment, research, and the potential commercialisation of PSP therapies.

South Korea’s pharmaceutical sales to hit $40.6b by 2028

It is expected to rise at a compound annual growth rate of 10% in US dollar terms.

South Korea unveils seven new projects under ARPA-H initiative

A total of $850m (KRW1.146t) will be allocated over nine years to support R&D efforts.

AMC prescribes VIVID Brain for stroke-related visual impairments

The digital therapeutic can customise treatment according to each patient’s progress.

South Korea's telemedicine market projected to reach $3.46b by 2029

It is driven by the increased healthcare demand due to an aging population and rising chronic disease.

Asan Medical Centre introduces Pluvicto for prostate cancer treatment

The treatment received official marketing approval in South Korea from the Ministry of Food and Drug Safety last May.

South Korea and Sweden discuss health and welfare cooperation

Both recognised the need to address the rapidly ageing population.

Seoul National University Hospital opens new lounge for cancer patients

The facility includes a centre that conducts lecture-type education and participatory programmes.

AMC and Intuitive Surgical ink MoU for robotic surgery education

The partnership will involve systematised training and pilot studies for new systems.

South Korean PCR systems market to grow at 5% CAGR through 2033

A key factor is Seegene's recent launch of a specialised PCR test in South Korea.

AMC harnesses AI for early kidney transplant rejection diagnosis

It focused on leveraging surface-enhanced Raman spectroscopy to detect low-concentration analytes.

Asan Medical Centre applies homomorphic encryption to lower breach risks

The tool was applied to a model that predicts mortality within 30 days post-surgery.

South Korea’s radiosurgery market to grow at 6% CAGR through 2033

Its expansion is attributed to a demand for advanced, minimally invasive treatments for neurological conditions,

Seoul St. Mary’s Hospital develops patient-derived meningioma organoids

Researchers used cells from patients to create a model similar to actual brain tumours.